drugs
AZ and MSD secure three bits of good news on key drug
August 18, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …
Longest-serving chief exec in NHS sacked for ‘gross misconduct’
August 18, 2017Medical Communications NHS, Newcastle, biotech, drugs, pharma, pharmaceutical
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …
Independent research may change the immunotherapy game
August 17, 2017Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical
Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
Alexion moves to bolster patent protection of Soliris
August 17, 2017Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Soliris brought in net sales of $2.8 billion last year for Alexion, meaning it accounted for close to 90% of …
Cancer Research UK and NU agree three-year research Astex Pharma deal
August 17, 2017Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
Massive increase in UK care home places needed by 2025, report finds
August 16, 2017Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care
A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …
Less sleep in children linked to increased risk of diabetes
August 16, 2017Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2
A study emerging from St George’s University of London found that children who slept an hour less than the recommended …
Mending broken hearts with an injectable patch
August 16, 2017Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical
A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …
Shire submits dry-eye drug for marketing approval
August 15, 2017Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical
Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …
Gilead set to open $250m, 23-acre campus
August 15, 2017Manufacturing and Production Gilead, biotech, drugs, pharma, pharmaceutical
Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …
Mundipharma agrees $250m ‘smart chemotherapy’ deal
August 15, 2017Manufacturing and Production, Sales and Marketing CellAct, Mundipharma, biotech, drugs, pharma, pharmaceutical
A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …
Over 1,000 currently active cancer trials spell trouble for patient recruitment
August 14, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical
The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
Early-stage study gives hope for rare and fatal neurodegenerative condition
August 11, 2017Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
Ending the era of $100,000 cancer drugs
August 11, 2017Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical
Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
One in twelve US doctors accepted opioid-related payments from pharma, finds study
August 10, 2017Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical
In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
